WO2021261971A1 - Composition for acne treatment or skin improvement - Google Patents

Composition for acne treatment or skin improvement Download PDF

Info

Publication number
WO2021261971A1
WO2021261971A1 PCT/KR2021/008052 KR2021008052W WO2021261971A1 WO 2021261971 A1 WO2021261971 A1 WO 2021261971A1 KR 2021008052 W KR2021008052 W KR 2021008052W WO 2021261971 A1 WO2021261971 A1 WO 2021261971A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
extract
purslane
ginger
broccoli
Prior art date
Application number
PCT/KR2021/008052
Other languages
French (fr)
Korean (ko)
Inventor
박시헌
금영삼
Original Assignee
박시헌
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 박시헌 filed Critical 박시헌
Publication of WO2021261971A1 publication Critical patent/WO2021261971A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/42Cucurbitaceae (Cucumber family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A composition for acne treatment is disclosed.

Description

여드름 치료 또는 피부개선용 조성물Composition for treating acne or improving skin
본 발명은 여드름 치료용 또는 피부개선용 조성물에 관한 것이다.The present invention relates to a composition for treating acne or improving skin.
여드름(심상성 좌창: acne vulgaris)은 청소년 및 성인에게서 흔히 나타나는 피부 질환으로서 피부의 피지선에 나타나는 염증성 질환이다.Acne vulgaris (acne vulgaris) is a common skin disease in adolescents and adults, and is an inflammatory disease that appears in the sebaceous glands of the skin.
국민건강보험공단이 2010년부터 2015년까지 지급한 요양급여와 관련된 자료를 분석한 결과, 주진단명으로 여드름 치료를 받은 인원은 2015년 110,758명으로 집계되었는데, 이는 2010년의 100,935명과 대비할 때 약 10% 증가한 것이다. 전체 여드름 치료를 받은 인원 중에서 20대가 43.1%로 가장 많았고, 이어서 10대가 31.1%로 두번째로 많았다.As a result of analyzing the data related to the medical care benefits paid by the National Health Insurance Corporation from 2010 to 2015, the number of people who received acne treatment as the main diagnosis was 110,758 in 2015, which is about 10 compared to 100,935 in 2010. % will increase. Among the total number of people who received acne treatment, those in their 20s accounted for the most at 43.1%, followed by those in their teens with 31.1%.
여드름의 원인과 종류는 성별과 연령대별로 상이하게 나타난다. 청소년기에는 호르몬의 변화가 여드름 발생의 주요 원인이며, 이마, 코와 같이 T 존이라 불리는 부위에 주로 나타난다.The causes and types of acne vary by gender and age group. In adolescence, hormonal changes are the main cause of acne, and it mainly appears in areas called T-zone, such as the forehead and nose.
반면, 성인의 여드름은 주로 스트레스, 음주, 불규칙한 생활습관 등 복합적인 이유로 발생하는 경우가 많고, 볼, 턱, 이마, 목 등 신체의 다양한 부위에서 발생한다. 성인의 여드름은 땀 또는 노폐물로 인하여 막힌 모공에서 발생하며, 재발율도 높다.On the other hand, adult acne is mainly caused by complex reasons such as stress, drinking, and irregular lifestyle, and occurs in various parts of the body such as the cheeks, chin, forehead, and neck. Adult acne occurs in pores clogged with sweat or waste products, and the recurrence rate is high.
여드름이 발생하고 나서 그대로 방치하는 경우, 여러 가지 문제가 발생할 수 있다. 여드름이 단순 염증에 그치는 것이 아니라, 피부 진피층에까지 문제를 일으켜 여드름 자국, 여드름 흉터, 넓어진 모공 등 다양한 2차 손상을 일으키기도 한다.If acne is left unattended after it occurs, various problems can occur. Acne is not just a simple inflammation, but also causes problems in the dermis layer of the skin, causing various secondary damages such as acne marks, acne scars, and enlarged pores.
여드름은 생활습관이 주 원인이 되는 경우가 많기 때문에, 일상 생활에서 꾸준히 관리하는 것이 권장된다. 따라서, 세안 시 불필요한 피부 자극을 최소화하고, 외부 자극물질로부터 피부를 보호하며, 실질적인 항균 효과를 나타내는 여드름 치료용 조성물 또는 여드름 피부 개선용 조성물을 개발할 필요가 있다.Since acne is often the main cause of lifestyle, it is recommended to manage it consistently in daily life. Therefore, there is a need to develop a composition for treating acne or a composition for improving acne prone skin that minimizes unnecessary skin irritation during washing, protects the skin from external irritants, and exhibits a substantial antibacterial effect.
본 발명은 상기와 같은 문제를 해결하기 위하여, 여드름 원인균에 대한 항균 효과를 나타내면서 피부 자극을 최소화할 수 있도록 천연물 추출물을 함유하는 여드름 치료용 조성물 또는 여드름 피부 개선용 조성물을 제공하기 위한 것이다.In order to solve the above problems, the present invention is to provide a composition for treating acne or a composition for improving acne prone skin containing a natural extract to minimize skin irritation while exhibiting an antibacterial effect on acne-causing bacteria.
본 발명은 생강 추출물, 녹차잎 추출물, 쇠비름 추출물, 오이 추출물, 병풀 추출물 및 브로콜리 추출물을 포함하는 여드름 치료용 조성물 또는 여드름 피부 개선용 조성물에 관한 것이다.The present invention relates to a composition for treating acne or a composition for improving acne prone skin, comprising a ginger extract, green tea leaf extract, purslane extract, cucumber extract, centella asiatica extract and broccoli extract.
본 발명의 조성물은 추가로 트레할로스를 포함할 수 있다.The composition of the present invention may further comprise trehalose.
본 발명의 조성물에서 상기 생강 추출물, 녹차잎 추출물, 쇠비름 추출물, 오이 추출물, 병풀 추출물 및 브로콜리 추출물은 전체 조성물에 대하여 각각 0.5 내지 5중량%를 포함할 수 있다. 또는 본 발명의 조성물에서 상기 생강 추출물, 녹차잎 추출물, 쇠비름 추출물, 오이 추출물, 병풀 추출물 및 브로콜리 추출물의 총합은 전체 조성물 중 3 내지 30중량%의 양으로 포함될 수 있다.In the composition of the present invention, the ginger extract, green tea leaf extract, purslane extract, cucumber extract, centella asiatica extract and broccoli extract may each contain 0.5 to 5% by weight based on the total composition. Alternatively, the total of the ginger extract, green tea leaf extract, purslane extract, cucumber extract, Centella asiatica extract and broccoli extract in the composition of the present invention may be included in an amount of 3 to 30% by weight of the total composition.
상기 생강 추출물, 녹차잎 추출물, 쇠비름 추출물, 오이 추출물, 병풀 추출물 및 브로콜리 추출물은 물, 유기용매 또는 이들의 혼합물로부터 추출될 수 있다. 예를 들어, 생강 추출물, 녹차잎 추출물, 쇠비름 추출물, 오이 추출물, 병풀 추출물 및 브로콜리 추출물은 각각 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리를 물, 메탄올, 에탄올, 에틸아세테이트 및 헥산으로 이루어진 군으로부터 선택된 1종 또는 2종 이상의 혼합물을 추출 용매로 하여 냉침법, 온침법 또는 항온진공추출법 등의 방법으로 추출할 수 있다. 바람직하게는 물, 에탄올 또는 물과 에탄올의 혼합물을 추출용매로 사용한다.The ginger extract, green tea leaf extract, purslane extract, cucumber extract, centella asiatica extract and broccoli extract may be extracted from water, an organic solvent, or a mixture thereof. For example, ginger extract, green tea leaf extract, purslane extract, cucumber extract, centella asiatica extract and broccoli extract are each of ginger, green tea leaf, purslane, cucumber, centella asiatica and broccoli in water, methanol, ethanol, ethyl acetate and hexane. One or a mixture of two or more selected from the group consisting of an extraction solvent may be used for extraction by a method such as cold acupuncture, warm acupuncture, or constant temperature vacuum extraction. Preferably, water, ethanol, or a mixture of water and ethanol is used as the extraction solvent.
이 때, 상기 각 추출물은 각 천연물(즉, 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리 각각)로부터 독립적으로 추출되거나, 또는 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리를 모두 혼합한 후 이 혼합물로부터 동시에 추출될 수 있다.At this time, each extract is independently extracted from each natural product (that is, each of ginger, green tea leaf, purslane, cucumber, centella asiatica and broccoli), or after mixing all of ginger, green tea leaf, purslane, cucumber, centella asiatica and broccoli It can be extracted simultaneously from this mixture.
본 발명의 조성물은 액상 제형, 현탁제 또는 에멀전 조성물 등으로 제제화될 수 있다. 바람직하게는 에멀전 조성물로 제제화된다.The composition of the present invention may be formulated as a liquid formulation, suspension or emulsion composition, and the like. Preferably formulated as an emulsion composition.
본 발명의 조성물은 여드름 치료용 약제 또는 화장료 또는 세정용으로 사용될 수 있다.The composition of the present invention may be used as a pharmaceutical or cosmetic for treating acne or for cleaning.
본 발명의 조성물은, 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리를 별도로 각각 추출 용매에 넣고, 가온, 실온 또는 냉온에서 추출하는 단계(a); 상기 단계(a)로부터 수득한 추출물을 건조하여 고형 추출물을 수득하는 단계(b); 및 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리 각 고형 추출물을 혼합하는 단계(c)를 포함하여 제조될 수 있다.The composition of the present invention, ginger, green tea leaves, purslane, cucumber, centella asiatica and broccoli separately in an extraction solvent, respectively, and extracting at warm, room temperature or cold temperature (a); drying the extract obtained from step (a) to obtain a solid extract (b); And it can be prepared including the step (c) of mixing each solid extract of ginger, green tea leaf, purslane, cucumber, centella asiatica and broccoli.
여기에서, 상기 추출 용매로는 물, 메탄올, 에탄올, 에틸아세테이트 및 헥산으로 이루어진 군으로부터 선택된 1종 또는 2종 이상의 혼합물이 사용될 수 있다.Here, as the extraction solvent, one or a mixture of two or more selected from the group consisting of water, methanol, ethanol, ethyl acetate and hexane may be used.
여기에서 상기 단계 (c)는, 상기 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리 각 추출물을 유기용매에 용해시키는 단계; 및 상기 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리 각 추출물이 용해된 유기용매를 계면활성제(예를 들어, 트레할로스 등)와 함께 물에 넣어 유화시켜 에멀전 조성물을 제조하는 단계를 포함할 수 있다.Here, the step (c) comprises dissolving each extract of ginger, green tea leaf, purslane, cucumber, centella asiatica and broccoli in an organic solvent; and emulsifying an organic solvent in which each extract of ginger, green tea leaf, purslane, cucumber, centella asiatica and broccoli is dissolved in water together with a surfactant (eg, trehalose, etc.) to prepare an emulsion composition. .
또한, 본 발명의 조성물은 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리를 모두 추출 용매에 넣고, 가온, 실온 또는 냉온에서 추출하는 단계(a); 상기 단계(a)로부터 수득한 추출물을 건조하여 고형 추출물을 수득하는 단계(b); 및 상기 고형 추출물을 포함하는 조성물을 제조하는 단계(c)를 포함하여 제조될 수 있다.In addition, the composition of the present invention, ginger, green tea leaves, purslane, cucumber, centella asiatica and broccoli all put in an extraction solvent, and extracting at warm, room temperature or cold temperature (a); drying the extract obtained from step (a) to obtain a solid extract (b); And it may be prepared including the step (c) of preparing a composition comprising the solid extract.
여기에서, 상기 추출 용매는 물, 메탄올, 에탄올, 에틸아세테이트 및 헥산으로 이루어진 군으로부터 선택된 1종 또는 2종 이상의 혼합물이 사용될 수 있다.Here, the extraction solvent may be one or a mixture of two or more selected from the group consisting of water, methanol, ethanol, ethyl acetate and hexane.
또한, 여기에서 상기 단계 (c)는, 상기 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리의 고형 추출물을 유기용매에 용해시키는 단계; 및 상기 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리의 고형 추출물이 용해된 유기용매를 계면활성제(예를 들어, 트레할로스 등)와 함께 물에 넣어 유화시켜 에멀전 조성물을 제조하는 단계를 포함할 수 있다.In addition, the step (c) here, the step of dissolving the solid extract of ginger, green tea leaf, purslane, cucumber, centella asiatica and broccoli in an organic solvent; and preparing an emulsion composition by emulsifying an organic solvent in which the solid extract of ginger, green tea leaves, purslane, cucumber, centella asiatica and broccoli is dissolved in water together with a surfactant (eg, trehalose, etc.) have.
생강(Zingiber officinale)은 외떡잎 식물 생강목 생강과의 여러해살이풀로서, 뿌리가 식용 및 약용으로 사용되며, 위액 분비 촉진 및 소화력 증진에 효과가 있는 것으로 알려져 있다.Ginger (Zingiber officinale) is a monocotyledonous perennial plant of the Ginger family, and its root is used for food and medicine, and is known to be effective in promoting gastric juice secretion and enhancing digestion.
녹차잎은 차나무(Camellia sinensis)의 잎으로서, 항산화 효과가 있는 것으로 알려져 있다.Green tea leaves are leaves of the tea tree (Camellia sinensis) and are known to have antioxidant effects.
쇠비름(Portulaca oleracea)은 쌍떡잎식물 중심자목 쇠비름과의 한해살이풀로서, 전초를 말린 것이 약용으로 사용되며, 동맥경화의 예방 등에 효능이 있는 것으로 알려져 있다.Purslane (Portulaca oleracea) is an annual plant of the dicotyledonous purslane family, and dried out herbs are used medicinally and are known to be effective in preventing arteriosclerosis.
오이(Cucumis sativus)는 쌍떡잎식물 합판화군 박목 박과의 한해살이 덩굴식물로서, 열매가 식용으로 사용되며, 체내 노폐물 배출의 효능이 있는 것으로 알려져 있다.Cucumber (Cucumis sativus) is an annual vine of the dicotyledonous plywood family, Gourdaceae, and its fruits are used for food and are known to have the effect of excreting wastes from the body.
병풀(Centella asiatica)은 쌍떡잎식물 이판화군 산형화목 미나리과의 여러해살이풀로서, 전초를 말린 것이 약용으로 사용되며, 위점막을 보호하는 효능이 있는 것으로 알려져 있다.Centella asiatica is a dicotyledonous perennial plant of the Dicotyledonous family Umbilicalaceae family, and dried out plants are used medicinally and are known to have the effect of protecting the gastric mucosa.
브로콜리(Brassica oleracea var. italica)는 쌍떡잎식물 양귀비목 겨자과의 한해살이풀로서, 줄기의 끝에 메달리는 작은 꽃뭉치를 식용 또는 약용으로 사용하며, 칼슘의 흡수를 촉진하여 뼈의 건강을 돕는 것으로 알려져 있다.Broccoli (Brassica oleracea var. italica) is an annual plant of the dicotyledonous papaveraceae mustard family, and small flower buds hanging from the tip of the stem are used for food or medicine, and it is known to promote calcium absorption and help bone health.
본 발명에 따른 조성물은 천연물 추출물을 함유하는 것으로서, 여드름 원인균에 대한 항균 효과를 나타내면서 피부 자극을 최소화할 수 있어서 안전하다.The composition according to the present invention contains a natural extract, and is safe because it can minimize skin irritation while exhibiting an antibacterial effect on acne-causing bacteria.
도 1은 본 발명에 따른 조성물의 항균력을 디스크 확산법으로 시험한 결과를 촬영한 사진이다.1 is a photograph of the results of testing the antimicrobial activity of a composition according to the present invention by a disk diffusion method.
도 2는 본 발명에 따른 조성물의 항균력을 광학 분석으로 시험한 결과를 촬영한 사진 및 그래프이다.2 is a photograph and graph of the results of testing the antimicrobial activity of the composition according to the present invention by optical analysis.
이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 사상 및 범위가 하기 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by way of Examples. However, the following examples are merely illustrative of the present invention, and the spirit and scope of the present invention are not limited by the following examples.
실시예Example 1: 천연물 추출 1: Natural product extraction
생강 100g을 물로 세척한 후, 건조시킨다. 건조된 것을 분쇄기(중국 Yunbang 사의 Pulverizer 2500A 분쇄기)로 분쇄한다. 이 분쇄물을 70% 에탄올 3ℓ에 넣고, 상온에서 교반하면서 5일간 침출한다. 침출액을 1000rpm으로 원심분리한 후 상층액을 회수하여 여과하고, 여액을 건조하여 고형의 추출물(extract) 10g을 수득하였다.100 g of ginger is washed with water and dried. The dried ones are pulverized with a pulverizer (Pulverizer 2500A pulverizer manufactured by Yunbang, China). This pulverized product is placed in 3 liters of 70% ethanol and leached for 5 days while stirring at room temperature. After centrifuging the leachate at 1000 rpm, the supernatant was collected and filtered, and the filtrate was dried to obtain 10 g of a solid extract.
녹차잎, 쇠비름, 오이, 병풀 및 브로콜리에 대해서도 위와 같은 공정을 통하여 추출물을 각각 9g, 10g, 11g, 9g 및 9g을 수득하였다.9g, 10g, 11g, 9g and 9g of extracts from green tea leaf, purslane, cucumber, centella asiatica and broccoli were obtained through the same process, respectively.
실시예Example 2: 지표물질의 확인 2: Identification of indicator substances
상기 실시예 1에서 수득한 각각의 추출물을 헥산 및 에틸아세테이트로 정제하였다. 정제된 각각의 추출물에 대하여 HPLC를 사용하여 지표 물질을 분리하여 확인하였다.Each extract obtained in Example 1 was purified with hexane and ethyl acetate. For each of the purified extracts, an indicator material was isolated and confirmed using HPLC.
HPLC 분석조건은 다음과 같다:HPLC analysis conditions are as follows:
컬럼 : 안지름 약 3mm, 길이 25cm인 스테인레스 강관에 공경 5㎛의 SUPELCOSILTM LC-NH2 HPLC 컬럼 (Sigma-Aldrich) Column: SUPELCOSIL TM LC-NH2 HPLC column (Sigma-Aldrich) with a pore diameter of 5 μm in a stainless steel tube with an inner diameter of about 3 mm and a length of 25 cm (Sigma-Aldrich)
이동상 : 메탄올-3차증류수 (46:35, v/v) (degassifying)Mobile phase: methanol-3 distilled water (46:35, v/v) (degassifying)
유속 : 1.1 mL/minFlow rate: 1.1 mL/min
칼럼온도 : 22 ℃Column temperature: 22 ℃
주입량 : 50 ㎕Injection volume: 50 μl
검출기 및 파장 : UV 흡광광도계 310 ㎚ (Bio-Rad)Detector and wavelength: UV absorbance meter 310 nm (Bio-Rad)
각각의 지표물질은 다음과 같다:Each indicator substance is as follows:
천연물natural product 지표물질indicator substance
구조식constitutional formula 화학식명chemical name
생강ginger
Figure PCTKR2021008052-appb-I000001
Figure PCTKR2021008052-appb-I000001
6-gingerol6-gingerol
녹차잎green tea leaves
Figure PCTKR2021008052-appb-I000002
Figure PCTKR2021008052-appb-I000002
(-)-epigallocatechin-3-gallate(-)-epigallocatechin-3-gallate
오이cucumber
Figure PCTKR2021008052-appb-I000003
Figure PCTKR2021008052-appb-I000003
β-sitosterolβ-sitosterol
쇠비름purslane
Figure PCTKR2021008052-appb-I000004
Figure PCTKR2021008052-appb-I000004
DaucosterolDaucosterol
병풀Centella asiatica
Figure PCTKR2021008052-appb-I000005
Figure PCTKR2021008052-appb-I000005
Asiatic acidAsiatic acid
브로콜리broccoli
Figure PCTKR2021008052-appb-I000006
Figure PCTKR2021008052-appb-I000006
GlucoraphaninGlucoraphanin
실시예 3: 에멀전 조성물 제조Example 3: Preparation of emulsion composition
하기 표 2의 조성 및 함량으로 100ml 용량의 조성물을 다음과 같이 제조한다:A composition with a capacity of 100 ml was prepared as follows with the composition and content of Table 2 below:
먼저, 유상부의 각 성분을 혼합하여 유상부 혼합물을 제조한다. 여기에 활성부(즉, 상기 실시예 1에서 수득한 각 고형 추출물)를 넣어 80℃로 가열하고, 220 bar 의 압력을 가하여 저속회전으로 교반하면서 용해시킨다.First, each component of the oil phase is mixed to prepare an oil phase mixture. The active part (that is, each solid extract obtained in Example 1) was put there, heated to 80° C., and dissolved while stirring at low speed by applying a pressure of 220 bar.
별도로 수상부의 각 성분을 혼합한 수상부 혼합물에 상기 각 고형 추출물이 용해된 유상부를 계면활성제와 함께 가한 후, 75℃ 온도로 유지하면서 정제수로 100ml이 되도록 표선한다. 이 혼합물을 75℃ 온도로 유지하면서, 저속회전 교반기에서 4시간 교반하여, 본 발명에 따른 에멀전 조성물을 제조한다.Separately, the oil phase in which each solid extract is dissolved is added to the aqueous phase mixture in which each component of the aqueous phase is mixed together with a surfactant, and then marked with purified water to make 100 ml while maintaining the temperature at 75°C. While maintaining the mixture at a temperature of 75° C., the mixture was stirred on a low-speed stirrer for 4 hours to prepare an emulsion composition according to the present invention.
Figure PCTKR2021008052-appb-T000001
Figure PCTKR2021008052-appb-T000001
실시예 4: C. acnes 에 대한 항균 시험Example 4: Antibacterial test against C. acnes
상기 실시예 3의 에멀전 조성물에 대하여, 여드름균인 C. acnes (Cutibacterium acnes) 항균 시험을 다음과 같이 디스크 확산법으로 실시하였다.With respect to the emulsion composition of Example 3, an antibacterial test for C. acnes (Cutibacterium acnes), which is an acne bacterium, was performed by the disk diffusion method as follows.
대조군으로는 생강 고형 추출물, 녹차잎 고형 추출물, 쇠비름 고형 추출물, 오이 고형 추출물, 병풀 고형 추출물 및 브로콜리 고형 추출물(각각 실시예 1에서 제조된 것을 사용함)과 항생제(암피실린)을 단독으로 함유하는 조성물(비교예 1 내지 7)을 사용하였다.As a control, a composition containing a ginger solid extract, a green tea leaf solid extract, a purslane solid extract, a cucumber solid extract, a centella asiatica solid extract, and a broccoli solid extract (each prepared in Example 1 was used) and an antibiotic (ampicillin) alone ( Comparative Examples 1 to 7) were used.
각 대조군(비교예 1 내지 7)의 조성은 하기 표 3과 같다(함량의 단위 (g/100ml)):The composition of each control group (Comparative Examples 1 to 7) is shown in Table 3 below (unit of content (g/100ml)):
Figure PCTKR2021008052-appb-T000002
Figure PCTKR2021008052-appb-T000002
또한, 상기 실시예 3의 조성물에서 계면활성제로서 트레할로스 대신에 수크로스를 사용한 조성물을 대조군(비교예 8)으로서 사용하였다(각 성분의 함량은 동일함).In addition, in the composition of Example 3, a composition using sucrose instead of trehalose as a surfactant was used as a control (Comparative Example 8) (the content of each component is the same).
비교예 8의 조성은 하기 표 4와 같다:The composition of Comparative Example 8 is shown in Table 4:
Figure PCTKR2021008052-appb-T000003
Figure PCTKR2021008052-appb-T000003
Reinforced Clostridial Medium(RCM)과 Bacteriological agar를 혼합한 플레이트 배지에 C. acnes 균주를 접종한 후, 디스크(지름 8mm)마다 그 안에 실시예 3 및 비교예 1 내지 8의 조성물 중 어느 하나를 30㎕씩 로딩하고, 파라필름으로 플레이트를 단단히 감싸서 산소를 차단시켰다.After inoculating the C. acnes strain on a plate medium mixed with Reinforced Clostridial Medium (RCM) and Bacteriological agar, 30 μl of any one of the compositions of Examples 3 and Comparative Examples 1 to 8 therein for each disk (diameter 8 mm) After loading, the plate was tightly wrapped with parafilm to block oxygen.
RCM 배지를 37℃ 인큐베이터 안에서 18시간 배양한 후, 실시예 3의 조성물 및 비교예 1 내지 7의 조성물에 대한 항균활성 억제 반경을 측정하였다. 실험 결과를 하기 표 5 및 도 1에 나타내었다(여기에서 억제반경은 원의 면적에서 디스크 면적을 뺀 값으로서, 단위는 mm2이다).After culturing the RCM medium in an incubator at 37° C. for 18 hours, the antibacterial activity inhibition radius for the composition of Example 3 and the compositions of Comparative Examples 1 to 7 was measured. The experimental results are shown in Table 5 and FIG. 1 (here, the suppression radius is a value obtained by subtracting the disk area from the area of the circle, and the unit is mm 2 ).
Figure PCTKR2021008052-appb-T000004
Figure PCTKR2021008052-appb-T000004
가. 각 천연물 추출물의 항균 활성 비교go. Comparison of antibacterial activity of each natural extract
실험 결과로부터, 각 추출물을 단독으로 사용한 경우(비교예 1 내지 6의 조성물)에는 C. acnes에 대한 항균활성이 거의 나타나지 아니하였으나, 본 발명에 따른 실시예 5의 조성물은 항균 활성이 나타남을 확인할 수 있었다.From the experimental results, when each extract was used alone (composition of Comparative Examples 1 to 6), antibacterial activity against C. acnes was hardly observed, but it was confirmed that the composition of Example 5 according to the present invention exhibited antibacterial activity. could
본 발명에 따른 실시예 3의 조성물이 양성 대조군인 암피실린 항생제의 항균 효과에는 다소 미치지 못하였으나, 항생제 투여 시 내성 발현 등과 같은 부작용이 발생하는 점에 비추어 볼 때, 본 발명의 조성물은 안전한 생약 추출물을 사용하여 부작용이 적으면서도 만족할 만한 항균 활성을 나타낸다는 점을 알 수 있었다.Although the composition of Example 3 according to the present invention did not achieve the antibacterial effect of the positive control, ampicillin antibiotic, side effects such as resistance expression occurred during administration of the antibiotic, the composition of the present invention was a safe herbal extract. It was found that it exhibits satisfactory antibacterial activity with few side effects.
나. 계면활성제 성분에 따른 항균 활성의 차이me. Differences in antibacterial activity according to surfactant components
계면활성제로서 수크로오스를 사용한 경우(비교예 8)에는 C. acnes에 대한 항균활성이 트레할로스를 사용한 실시예 3의 조성물의 항균활성보다 적게 나타났다.When sucrose was used as a surfactant (Comparative Example 8), the antibacterial activity against C. acnes was less than that of the composition of Example 3 using trehalose.
실시예Example 5: 항균 활성에 대한 광학적 분석 5: Optical analysis for antibacterial activity
C. ances 균주가 108/ml 의 농도로 존재하는 RCM 배지(증류수에 분산된 것) 10ml을 시험관에 넣는다. 여기에, 실시예 3의 조성물 및 비교예 8의 조성물을 각각 최종 혼합물에 대하여 10㎍/ml 또는 30㎍/ml 의 농도가 되도록 넣어 혼합한다. 이 혼합물이 들어 있는 시험관을 37℃ 진탕 인큐베이터 내에서 18시간 배양하였다.10 ml of RCM medium (dispersed in distilled water) in which the C. ances strain is present at a concentration of 10 8 /ml is placed in a test tube. Here, the composition of Example 3 and the composition of Comparative Example 8 are put and mixed to have a concentration of 10 μg/ml or 30 μg/ml with respect to the final mixture, respectively. The test tube containing this mixture was incubated for 18 hours in a shaking incubator at 37°C.
이후, 흡광도(OD 600nm)를 광학 분석하여, 균주의 농도를 분석하였다. 분석 결과는 도 2에 나타내었다.Then, by optically analyzing the absorbance (OD 600nm), the concentration of the strain was analyzed. The analysis results are shown in FIG. 2 .
분석 결과, 트레할로스를 사용한 본 발명의 조성물에 대해서 항균 활성이 나타났으나, 수크로스를 사용한 대조군의 조성물에서는 항균 활성이 거의 나타나지 아니하였다.As a result of the analysis, antibacterial activity was shown for the composition of the present invention using trehalose, but almost no antibacterial activity was shown in the composition of the control group using sucrose.
이는 수크로스를 사용하는 경우 유화가 제대로 이루어지지 못하여 항균 활성이 저하되었기 때문인 것으로 추측된다.It is presumed that this is because, when sucrose is used, emulsification is not performed properly and the antibacterial activity is lowered.
이와 같이, 본 발명의 조성물에서 계면활성제로는 트레할로스가 적합하다는 것을 확인할 수 있었다.As such, it was confirmed that trehalose was suitable as a surfactant in the composition of the present invention.
본 발명의 조성물은 여드름 원인균에 대한 항균 효과를 나타내면서 피부 자극을 최소화할 수 있는 안전한 조성물이다.The composition of the present invention is a safe composition that can minimize skin irritation while exhibiting an antibacterial effect on acne-causing bacteria.

Claims (14)

  1. 생강, 녹차, 쇠비름, 오이, 병풀, 브로콜리의 각 추출물을 포함하는 여드름 치료용 의약 조성물.A pharmaceutical composition for treating acne comprising extracts of ginger, green tea, purslane, cucumber, centella asiatica, and broccoli.
  2. 제1항에 있어서, 트레할로스를 더 포함하는 조성물.The composition of claim 1 , further comprising trehalose.
  3. 제1항에 있어서, 제형이 에멀전인 조성물.The composition of claim 1 , wherein the formulation is an emulsion.
  4. 생강, 녹차, 쇠비름, 오이, 병풀, 브로콜리의 각 추출물을 포함하는 여드름 피부 개선용 조성물.A composition for improving acne skin comprising extracts of ginger, green tea, purslane, cucumber, centella asiatica, and broccoli.
  5. 제4항에 있어서, 화장료로 사용되는 것을 특징으로 하는 조성물.The composition according to claim 4, wherein the composition is used as a cosmetic.
  6. 제4항에 있어서, 세정용으로 사용되는 것을 특징으로 하는 조성물.The composition according to claim 4, characterized in that it is used for cleaning.
  7. 제4항에 있어서, 트레할로스를 더 포함하는 조성물.5. The composition of claim 4, further comprising trehalose.
  8. 제4항에 있어서, 제형이 에멀전인 조성물.5. The composition of claim 4, wherein the formulation is an emulsion.
  9. 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리를 별도로 각각 추출 용매에 넣고, 가온, 실온 또는 냉온에서 추출하는 단계(a);Ginger, green tea leaf, purslane, cucumber, centella asiatica and broccoli are separately put in an extraction solvent, respectively, and extracted at warm, room temperature or cold temperature (a);
    상기 단계(a)로부터 수득한 추출물을 건조하여 고형 추출물 수득하는 단계(b);Drying the extract obtained from step (a) to obtain a solid extract (b);
    생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리 각 고형 추출물을 혼합하는 단계(c)를 포함하는, 여드름 치료용 또는 여드름 피부 개선용 조성물의 제조 방법.A method of producing a composition for treating acne or improving acne skin, comprising the step (c) of mixing each solid extract of ginger, green tea leaves, purslane, cucumber, centella asiatica and broccoli.
  10. 제9항에 있어서, 상기 추출 용매는 물, 메탄올, 에탄올, 에틸아세테이트 및 헥산으로 이루어진 군으로부터 선택된 1종 또는 2종 이상의 혼합물인 것을 특징으로 하는 제조 방법.The method according to claim 9, wherein the extraction solvent is one or a mixture of two or more selected from the group consisting of water, methanol, ethanol, ethyl acetate and hexane.
  11. 제9항에 있어서, 상기 단계 (c)는,The method of claim 9, wherein step (c) comprises:
    상기 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리 각 추출물을 유기용매에 용해시키는 단계;Dissolving each extract of ginger, green tea leaf, purslane, cucumber, centella asiatica and broccoli in an organic solvent;
    상기 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리 각 추출물이 용해된 유기용매를 계면활성제와 함께 물에 넣어 유화시켜 에멀전 조성물을 제조하는 단계를 포함하는 것인 제조 방법.A manufacturing method comprising the step of preparing an emulsion composition by emulsifying an organic solvent in which each extract of ginger, green tea leaf, purslane, cucumber, centella asiatica and broccoli is dissolved in water together with a surfactant.
  12. 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리를 모두 추출 용매에 넣고, 가온, 실온 또는 냉온에서 추출하는 단계(a);Ginger, green tea leaves, purslane, cucumber, centella asiatica and broccoli all put in an extraction solvent, and extracting at warm, room temperature or cold temperature (a);
    상기 단계(a)로부터 수득한 추출물을 건조하여 고형 추출물을 수득하는 단계(b);drying the extract obtained from step (a) to obtain a solid extract (b);
    상기 고형 추출물을 포함하는 조성물을 제조하는 단계(c)를 포함하는, 여드름 치료용 또는 여드름 피부 개선용 조성물의 제조 방법.A method of preparing a composition for treating acne or improving acne skin, comprising the step (c) of preparing a composition comprising the solid extract.
  13. 제12항에 있어서, 상기 추출 용매는 물, 메탄올, 에탄올, 에틸아세테이트 및 헥산으로 이루어진 군으로부터 선택된 1종 또는 2종 이상의 혼합물인 것을 특징으로 하는 제조 방법.The method according to claim 12, wherein the extraction solvent is one or a mixture of two or more selected from the group consisting of water, methanol, ethanol, ethyl acetate and hexane.
  14. 제12항에 있어서, 상기 단계 (c)는,The method of claim 12, wherein step (c) comprises:
    상기 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리의 고형 추출물을 유기용매에 용해시키는 단계;dissolving the solid extracts of ginger, green tea leaves, purslane, cucumber, centella asiatica and broccoli in an organic solvent;
    상기 생강, 녹차잎, 쇠비름, 오이, 병풀 및 브로콜리의 고형 추출물이 용해된 유기용매를 계면활성제와 함께 물에 넣어 유화시켜 에멀전 조성물을 제조하는 단계를 포함하는 것인 제조 방법.A manufacturing method comprising the step of preparing an emulsion composition by emulsifying an organic solvent in which the ginger, green tea leaves, purslane, cucumber, centella asiatica and broccoli solid extracts are dissolved in water together with a surfactant.
PCT/KR2021/008052 2020-06-26 2021-06-26 Composition for acne treatment or skin improvement WO2021261971A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020200078644A KR102170850B1 (en) 2020-06-26 2020-06-26 A composition for treating acne or improving acne skin
KR10-2020-0078644 2020-06-26

Publications (1)

Publication Number Publication Date
WO2021261971A1 true WO2021261971A1 (en) 2021-12-30

Family

ID=73397884

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2021/008052 WO2021261971A1 (en) 2020-06-26 2021-06-26 Composition for acne treatment or skin improvement

Country Status (2)

Country Link
KR (1) KR102170850B1 (en)
WO (1) WO2021261971A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230171869A (en) 2022-06-14 2023-12-21 이승창 Pharmaceutical composition for prevention or treatment of acne

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080006568A (en) * 2005-03-30 2008-01-16 레반스 테라퓨틱스, 아이엔씨. Compositions and methods for treating acne
JP2011093835A (en) * 2009-10-29 2011-05-12 Noevir Co Ltd Skin care preparation
KR20180017974A (en) * 2016-08-12 2018-02-21 (주)한국융합기술연구소 Cosmetic composition for preventing or treating acne comprising combined herbal extracts
KR20180137952A (en) * 2017-06-20 2018-12-28 (주)지유본초 Mask pack

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100491746B1 (en) 1997-06-02 2005-09-02 주식회사 엘지생활건강 Composition for prevention and treatment of acne containing P. oleracea extract

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080006568A (en) * 2005-03-30 2008-01-16 레반스 테라퓨틱스, 아이엔씨. Compositions and methods for treating acne
JP2011093835A (en) * 2009-10-29 2011-05-12 Noevir Co Ltd Skin care preparation
KR20180017974A (en) * 2016-08-12 2018-02-21 (주)한국융합기술연구소 Cosmetic composition for preventing or treating acne comprising combined herbal extracts
KR20180137952A (en) * 2017-06-20 2018-12-28 (주)지유본초 Mask pack

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JANG, MIN-WOO; HA, BAE-JIN: "Effects of Broccoli on Anti-inflammation and Anti-oxidation According to Extraction Solvent", JOURNAL OF FOOD HYGIENE AND SAFETY, vol. 27, no. 4, 31 December 2012 (2012-12-31), pages 461 - 465, XP009533192, ISSN: 1229-1153, DOI: 10.13103/JFHS.2012.27.4.461 *

Also Published As

Publication number Publication date
KR102170850B1 (en) 2020-11-02

Similar Documents

Publication Publication Date Title
Jaiarj et al. Anticough and antimicrobial activities of Psidium guajava Linn. leaf extract
CN108904376B (en) Traditional Chinese medicine compound fermentation liquor for cosmetics with oil control and acne removal effects and preparation and application thereof
WO2019103329A1 (en) Antioxidant composition comprising fermented mealworm extract as active ingredient
gowdu Viswanathan et al. Antimicrobial activity of bioactive compounds and leaf extracts in Jatropha tanjorensis
CN104998153A (en) Sterilization disinfectant for clinical laboratory and preparation method thereof
CN106619380A (en) Anti-acne essence
CN111973515B (en) Bacteriostatic restoration plant extraction composition, preparation method and application thereof
WO2021261971A1 (en) Composition for acne treatment or skin improvement
WO2019225785A1 (en) Antimicrobial and antifungal composition comprising eugenol and gallic acid as active ingredients
KR20110128385A (en) The herb medicine composition material and the manufacturing process for pimple skin-improvement uses by midam cheonggyeolan
JPH0616530A (en) Cosmetic
CN113274455A (en) Traditional Chinese medicine composition and application thereof
WO2009134021A2 (en) A composition of plants extract for alleviation of pruritus
Ekwenye et al. Antibacterial effect of Phyllanthus niruri (Chanca Piedra) on three enteropathogens in man
KR20110130184A (en) An extract of cudrania tricuspidata and a cosmetic composition containing the extract with anti-acne effect
Raisagar et al. Comparative study of wound healing effect of bark extracts of Ficus religiosa & Ficus benghalensis by mice model
CN107912463A (en) A kind of Chinese and Western combines disinfection solution and preparation method
Islam et al. Antidiabetic, cytotoxic activities and phytochemical screening of Peltophorum pterocarpum (DC.) K. Heyne root
Luka et al. Phytochemical screening and in vitro evaluation of antibacterial activity of aqueous and ethanolic extracts of root and stem bark of Bridelia ferruginea. Benth.(Euphorbiaceae)
WO2018131780A1 (en) Composition for preventing or treating gastritis or peptic ulcer
Acheampong et al. Antioxidant and antimicrobial activity of the methanol and petroleum ether extracts of the stem of Microdesmis puberula
CN111803599B (en) Acne-removing external traditional Chinese medicine composition and preparation thereof
WO2022010035A1 (en) Pharmaceutical composition for anticancer comprising herbal extract
EP2793917B1 (en) Extract of rhus copallina extract for use as a medicament
WO2013147409A1 (en) Natural extract for preventing and treating oral disease

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21829140

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21829140

Country of ref document: EP

Kind code of ref document: A1